newsfilter
← Latest News
PR Newswire·

Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of...